Answers are grounded in this paper and cite their sources.
Laboratory study reveals high-yield preparation of iodine-131-labeled human growth hormone with intact immunoreactivity, indicating a reliable protocol for sensitive biological assays.
A simple and rapid method is presented for the preparation of I/sup 131/- labeled human growth hormone of high specific radioactivity (240-300 mu C/ mu g). Low amounts of carrierfree I/sup 131/ iodide (2 mC) are allowed to react, without prior treatment, with small quantities of protein (5 mu g) in a highyield reaction (approx. 70% transfer of I/sup 131/ to protein). The degree of chemical substitution is minimized (0.5- 1.0 atom of iodine/molecule of protein) by the use of carrier-free I/sup 131/ iodide. The I/sup 131/-labeled hormone (up to 300 mu C/ mu g) contains no detectable degradation products and is immunologically identical with the unlabeled hormone. The loss of immunological reactivity at high specific radioactivities or at high levels of chemical substitution with STAI/sup 127/!iodine is demonstrated. (auth)
No takes yet. Share an insight, caveat, or question.
Greenwood et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: